Vitamin B6 in Health Supplements and Neuropathy: Case Series Assessment of Spontaneously Reported Cases

Florence Hunsel (), Sonja de Koppel, Eugène Puijenbroek and Agnes Kant
Additional contact information
Florence Hunsel: Netherlands Pharmacovigilance Centre Lareb
Sonja de Koppel: Netherlands Pharmacovigilance Centre Lareb
Eugène Puijenbroek: Netherlands Pharmacovigilance Centre Lareb
Agnes Kant: Netherlands Pharmacovigilance Centre Lareb

Drug Safety, 2018, vol. 41, issue 9, No 5, 859-869

Abstract: Abstract Introduction In the literature, vitamin B6 has been linked to the development of polyneuropathy. Most often, these complaints were seen when taking high doses of vitamin B6 for a long time. Evidence as to whether a lower dosage range of vitamin B6 (

Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1007/s40264-018-0664-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:41:y:2018:i:9:d:10.1007_s40264-018-0664-0

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-018-0664-0

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().